BMN 351
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMN 351, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy [Phase 1, Phase 2]